About
I am an early-career postdoctoral researcher within the Cardiac Drug Discovery Group at QIMR Berghofer. I completed my Bachelor of Biomedical Science with Honours (2016) at the University of Queensland, followed by a PhD (conferred 2022) at QIMR Berghofer under the mentorship of A/Prof Michelle Hill. During my PhD, I specialised in developing and applying multi-omics techniques to investigate aggressive prostate cancer [1,2] and COVID-19 [3,4], leading to the discovery of novel diagnostic tools and therapeutic targets.
At present, my research is primarily centred on proteomics-based approaches to uncover the molecular mechanisms underlying cardiac pathophysiology. I lead the acquisition and analysis of proteomics, phosphoproteomics, and interactomics data to better understand the dysregulated signalling networks contributing to heart failure [5]. Additionally, I am developing innovative tools to explore clinically relevant applications of phosphoproteomics, with support from QIMRB small grants. This work contributes to expanding our drug development pipeline, with the ultimate goal of advancing therapeutic strategies for cardiovascular diseases.
Research Skills
- Proteomics
- Phosphoproteomics, and other protein post-translational modifications
- Interactomics: Protein-protein interactions and small molecule-protein interactions
- Fourier transform infrared spectroscopy
- Development of innovative experimental tools and methodologies
Professional Associations
- Australian Proteomics Society (Member)
- Human Proteome Organisation (Member)
- Australian Society for Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) (Member)
Funding
- Queensland Inflammation Research Centre seed grant “Investigating Cytokine-Driven Cardiac Dysfunction in Rheumatoid Arthritis Using Longitudinal Data and Human Cardiac Organoids” (CIA) – 2025
- US Department of Defense - Parkinson’s Research Program “The Nose Knows: Harnessing Human Olfactory Cells to Identify Biomarkers of Nonmotor Changes in Parkinson’s Disease” (Named investigator) – 2024 – 2027
- QIMR Berghofer Leadership Development Grant “Targeting ANKRD1 as a regulator of contractile deficits in cardiac fibrosis” – 2024-2025
- QIMR Berghofer Access to Equipment, Services, Technology Platforms, Datasets Grant “Developing spatial phosphoproteomics to study paracrine signalling in cardiac tissue” – 2024-2025
Publications
Robinson, H., Ruelcke, J. E., Lewis, A., Bond, C. S., Fox, A. H., Bharti, V., Wani, S., Cloonan, N., Lai, A., Margolin, D., Li, L., Salomon, C., Richards, R. S., Farrell, A., Gardiner, R. A., Parton, R. G., Cristino, A. S. & Hill, M. M. 2021. Caveolin-1-driven membrane remodelling regulates hnRNPK-mediated exosomal microRNA sorting in cancer. Clinical and Translational Medicine, 11, e381.
Robinson, H., Roberts, M. J., Gardiner, R. A. & Hill, M. M. 2023. Extracellular vesicles for precision medicine in prostate cancer – Is it ready for clinical translation? Seminars in Cancer Biology, 89, 18-29.
Banerjee, A., Gokhale, A., Bankar, R., Palanivel, V., Salkar, A., Robinson, H., Shastri, J. S., Agrawal, S., Hartel, G., Hill, M. M. & Srivastava, S. 2021. Rapid Classification of COVID-19 Severity by ATR-FTIR Spectroscopy of Plasma Samples. Analytical Chemistry, 93, 10391-10396.